Magnetar Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Magnetar Financial’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	81,001 +70,799	+694%	+$951K	0.01%	476
2025 Q4	$129K	Buy	+10,202	New	+$117K	﹤0.01%	834
2025 Q2	–	Sell	-29,605	Closed	-$248K	–	886
2025 Q1	$248K	Sell	29,605 -18,199	-38%	-$152K	﹤0.01%	614
2024 Q4	$379K	Buy	+47,804	New	+$401K	0.01%	423
2021 Q3	–	Sell	-119,317	Closed	-$611	–	1305
2021 Q2	$611	Buy	+119,317	New	+$678K	0.01%	838
2021 Q1	–	Sell	-551,792	Closed	-$2.52M	–	1037
2020 Q4	$2.52M	Buy	+551,792	New	+$2.45M	0.04%	322
2018 Q3	–	Sell	-170,531	Closed	-$2.8M	–	509
2018 Q2	$2.8M	Buy	+170,531	New	+$2.99M	0.04%	89

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return